---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-004799"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2025-04-15T23:59:59+00:00"
generated_at: "2026-05-23T14:52:11.619270+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Anebulo regains Nasdaq compliance on private placement share restrictions

## Summary
- Nasdaq confirmed compliance with Listing Rule 5635(b) on April 11, 2025.
- Removal of voting and transfer restrictions on shares issued in December 2024 private placement was approved by stockholders.
- Matter is now closed; no further delisting risk from this issue.
- Company disclosed the resolution in an 8-K filed April 15, 2025.

## SEC filing metadata
- accession: 0001641172-25-004799
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2025-04-15T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000164117225004799/0001641172-25-004799-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000164117225004799/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-004799
- JSON: https://secwatch.observer/filing/0001641172-25-004799.json
- Plain text: https://secwatch.observer/filing/0001641172-25-004799.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.